Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 1999, p. 371-373, Vol. 43, No. 2
0066-4804/99/$00.00+0
Fungal Lethality, Binding, and Cytotoxicity
of Syringomycin-E
A. J.
De
Lucca,1,*
T. J.
Jacks,1
J.
Takemoto,2
B.
Vinyard,3
J.
Peter,4
E.
Navarro,4 and
T.
J.
Walsh4
Southern Regional Research Center,
Agricultural Research Service, U.S. Department of Agriculture, New
Orleans, Louisiana1;
Department of
Biology, Utah State University, Logan, Utah2;
Biometrical Consulting Service, Agricultural Research
Service, U.S. Department of Agriculture, Beltsville,
Maryland3; and
Immunocompromised
Host Section, Pediatric Branch, National Cancer Institute, National
Institutes of Health, Bethesda, Maryland4
Received 13 January 1998/Returned for modification 21 May
1998/Accepted 4 December 1998
 |
ABSTRACT |
Syringomycin-E (SE) was significantly lethal to
Aspergillus and Fusarium species at between 1.9 and 7.8 µg/ml. SE complexed with the following fungal wall
constituents (in order of binding):
-1,3-glucan > chitin > mannan > ergosterol = cholesterol. Cytotoxicity in HeLa
cells was proportional to the SE concentration, while the amount
required for cytotoxicity was 3 to 20 times that needed to kill 95% of
the fungi tested.
 |
TEXT |
Fungi are important medical
pathogens that are increasingly resistant to current control
strategies. This situation has prompted increased efforts to find novel
antimicrobial agents. Peptides from widely divergent species have been
studied for their antimicrobial properties. For example, cecropins,
present in insects and pigs, have potent antimicrobial activity
(7, 8, 11-13). Syringomycins, which are produced by
Pseudomonas syringae, are a new class of potent
antimicrobial peptides. They are small, cyclic lipodepsinonapeptides (approximately 1,200 kDa), of which syringomycin-E (SE) is the major form (17, 21). SE (molecular weight, 1,240) and
related P. syringae cyclic lipodepsinonapeptides have been
considered putative virulence factors against plants. However, some
strains produce these peptides and are saprophytic, indicating that SE is not the primary cause of plant disease (1). SE was
evaluated in vitro with standard broth microdilution assays and found
to inhibit the medically important yeasts Aspergillus
fumigatus, Mucor sp., and Trichophyton sp.
(18). SE action in yeast is influenced by sterols and may
involve formation of voltage-sensitive ion channels of weak anion
selectivity (10, 20).
Aspergillosis and fusariosis are life-threatening mycoses in
immunocompromised hosts. The most prevalent species causing
aspergillosis are A. flavus, A. fumigatus,
and A. niger (9, 15, 23). Fusarium species are emerging pathogens that are
resistant to amphotericin B in immunocompromised patients
(2, 3, 16). Little is known about the activity of SE
against these species of medically important filamentous fungi, nor is
the physiological interaction between SE and such fungi understood. We
therefore studied the potential lethality of SE for A. flavus, A. niger, A. fumigatus,
Fusarium moniliforme, and Fusarium oxysporum. We also explored the physicochemical interactions between SE and fungal
wall components, as well as the cytotoxicity of SE for HeLa cells.
Bioassays to determine SE lethalities against fungi.
Fungi
were grown on potato dextrose agar (Difco, Detroit, Mich.) slants for 7 days (30°C). Conidia were harvested in 1% potato dextrose broth
(PDB), pH 5.0 (Difco). Conidial suspensions (104
conidia/ml) were incubated for 8 h (30°C) to obtain germinating conidia (6). Viable conidial numbers were consistent with
the high percentage observed earlier (7). Nongerminating
conidia (104 conidia/ml) were used immediately. Control
samples consisted of 45 µl of conidia plus 405 µl of 1% PDB. Test
samples were composed of 45 µl of conidia and the appropriate volumes
of stock SE and 1% PDB to give the desired peptide concentration,
ranging from 0.05 to 6.4 µM, in a volume of 450 µl. SE was produced
as previously described (4). SE was purified to homogeneity
based on high-performance liquid chromatography profiles and fast atom
bombardment mass spectroscopy analysis. Samples were mixed, incubated,
and plated out as previously described (7, 8).
Determination of peptide binding to fungal conidial walls and
mammalian components.
We determined the ability of SE to complex
with fungal conidial constituents, which included ergosterol and
cholesterol (Sigma Chemical Co., St. Louis, Mo.), mannan (Sigma
Chemical Co.), chitin (a gift from B. Triplett, Southern Regional
Research Center, U.S. Department of Agriculture), and
-1,3-glucan
(Wako Pure Chemical Co., Osaka, Japan). Polymers and sterols were
finely dispersed with ground-glass hand homogenizers. The final SE
concentration in the SE control and all test mixtures was 23.8 µg/ml.
Ergosterol and cholesterol (final concentrations, 1.8 × 10
3 M) were separately mixed with SE, as were
-1,3-glucan, chitin, and mannan (final concentrations, 200 µg/ml).
Binding assays were performed three separate times, each time in
triplicate. After gentle mixing, test samples and SE controls were
incubated for 30 min at 37°C. Samples were centrifuged at 8,000 × g (10 min) in a swinging bucket. Degrees of dispersion
before and after centrifugation were not determined. After
centrifugation, lipids formed floating fat pads and polymers formed
pellets. This force easily removed insoluble sterols and other fungal
wall constituents, producing a clear supernatant for peptide analysis.
Unbound peptide concentrations in solution were determined by the
Waddell method (22), which estimates contents of peptide
bonds independent of aromatic residues. For our purposes, this method
was preferred to other estimations for protein content, according to
criteria published earlier (24).
Cytotoxicity assay.
Human epithelioid cervical carcinoma cells
(HeLa cells; ATCC 2.2CCL) were grown in minimal essential medium
(Mediatech) supplemented with fetal bovine sera and penicillin. The
cells were rinsed with phosphate-buffered saline and harvested with
trypsin. Cell counts were determined manually with trypan blue, and
cells were diluted to a final concentration of 2.5 × 105 CFU/ml. Aliquots of 100 µl per well were dispensed in
a 96-well plate. Cells were incubated overnight (18 to 24 h) at
37°C in a humidified 5% CO2 environment. Neutral red dye
solution was then added to each well, and the mixtures were reincubated
for 3 h. Twofold serial dilutions of SE were prepared to final
concentrations of 30, 15, 7.5, and 3.5 µM. Negative controls (without
peptide) were included. Cells were exposed to the peptide for 1 h.
These experiments consisted of three wells per concentration in each of
three experiments. Supernatants from each well were transformed into
another 96-well plate. The remaining cells were lysed with a 2% Triton
solution. Glacial acetic acid was then added to supernatants and
lysates and read at A540.
Statistical analysis.
Viable count bioassays with SE were
performed on three separate occasions per fungus. Analysis of variance
and the least-significant-difference test were performed on the data.
Data were pooled by sample type (n = 24). A 95% level
of significance was used. Gompertz plot analysis was employed to
determine the significance of the fungicidal properties of SE for the
tested fungi relative to those of cecropins A and B and dermaseptin, as
published previously by our laboratory (7, 8).
SE lethality for fungi.
SE proved to be significantly lethal
for the germinated conidia of the test aspergilli (Fig.
1A). Nearly all of the germinated A. niger and A. fumigatus conidia were killed at
an SE concentration of 1.9 µg/ml. The number of CFU was reduced by
95% at 7.8 µg of SE per ml for the germinated conidia of A. flavus. SE did not affect the nongerminated conidial viability of
the tested Aspergillus species. SE was rapidly and
significantly effective against Fusarium species (Fig. 1B).
At 1.9 µg/ml, CFU viabilities of the nongerminated and germinated
conidia of F. moniliforme and F. oxysporum were reduced by 95 and 99%, respectively.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
SE lethality for nongerminated and germinated
Aspergillus (A) and Fusarium (B) conidia. Values
are means ± standard errors.
|
|
Binding of SE to cell wall and membrane constituents.
Less
than 1% of the ergosterol or cholesterol bound with SE. The fungal
wall constituents chitin, mannan, and
-1,3-glucan bound 3.3, 4.2, and 10.7%, respectively, of the SE. Variabilities of binding were less
than 0.1%.
Cytotoxicity assay.
Percent cytotoxicity of SE against HeLa
cells was directly related to the concentration of the peptide (Fig.
2). The threshold for cytotoxicity
appeared to be
12 µg/ml. At concentrations of less than 12 µg/ml,
cell viability appeared to be slightly enhanced, while at
concentrations of
12 µg/ml, cytotoxicity increased in direct
relation to the increased levels of SE. These findings indicate that SE
has minimum to no cytotoxicity at concentrations which have
95%
lethality against germinating conidia of A. flavus, A. fumigatus, and A. niger, as well as nongerminated and
germinating conidia of F. moniliforme and F. oxysporum.
Sorensen et al. (18) showed that SE causes lysis of sheep
erythrocytes. However, comparison of our bioassay data with their erythrocyte cytotoxicity data shows that SE reduces fungal viability by
90 to 98% at concentrations producing less than 20% release of
hemoglobin from erythrocytes. Lethality for erythrocytes does not
necessarily mean that a compound cannot be used as an antibiotic. Amphotericin, by comparison, also causes hemolysis (5, 14) but does so at concentrations above those used therapeutically. Structural modification of SE may improve the therapeutic index of this
potent peptide. It should be noted that the HeLa cytotoxicity assay
cannot predict toxicity of SE in humans and animals.
We determined the lethality of SE for fungi relative to the lytic
peptides cecropin A, cecropin B, and dermaseptin, which we studied
previously (7, 8). Statistical analysis with Gompertz plots
showed SE to be significantly more fungicidal than these peptides
against the tested germinated conidia of Aspergillus spp.
and to be the second most lethal against the tested Fusarium spp. Comparisons of binding studies with these peptides show that SE
has different binding properties for chitin,
-1,3-glucan, and mannan
than do cecropins A and B and dermaseptin. The latter peptides have
much higher affinities for fungal sterols than does SE (7,
8).
While SE is lethal for filamentous fungi, carefully designed in vivo
toxicological studies are necessary to further define its safety
profile for topical and systemic administration. Recently, SE was not
detected at levels above 8.0 µg per gram of tissue in mice receiving
topical treatments of SE in 12% (wt/vol) formulations (19).
This finding and the cytotoxicity and bioassay results reported
here suggest that SE has potential for development as a novel
agent against invasive fungal infections.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Southern
Regional Research Center, 1100 Robert E. Lee Blvd., New Orleans, LA
70124. Phone: (504) 286-4253. Fax: (504) 286-4419. E-mail:
adelucca{at}nola.srrc.usda.gov.
 |
REFERENCES |
| 1.
|
Adetuyi, F.,
A. Isogai,
D. Di Giorgio,
A. Ballio, and J. Y. Takemoto.
1995.
Saprophytic Pseudomonas syringae strain M1 of wheat produces cyclic lipodepsipeptides.
FEMS Microbiol. Lett.
131:63-67[Medline].
|
| 2.
|
Anaissie, E.,
H. Kantarjian,
J. Ro,
R. Hopfer,
K. Rolston,
V. Fainstein, and G. Bodey.
1988.
The emerging role of Fusarium infections in patients with cancer.
Medicine (Baltimore)
67:77-83[Medline].
|
| 3.
|
Auswick, P. K. C.
1986.
Fusarium infections in man and animals, p. 129-140.
In
M. D. Moss, and J. E. Smith (ed.), The applied mycology of Fusarium. Cambridge University Press, New York, N.Y.
|
| 4.
|
Bidwai, A. P.,
L. Zhang,
R. C. Bachmann, and J. Y. Takemoto.
1987.
Mechanism of action of Pseudomonas syringae phytotoxin, syringomycin: stimulation of red beet plasma membrane ATPase activity.
Plant Physiol.
83:39-43[Abstract/Free Full Text].
|
| 5.
|
Brajtburg, J.,
W. G. Powderly,
G. S. Kobayashi, and G. Modoff.
1990.
Amphotericin: current understanding of mechanism of action.
Antimicrob. Agents Chemother.
34:183-188[Free Full Text].
|
| 6.
|
De Lucca, A. J.,
T. J. Walsh, and D. J. Daigle.
1996.
N-Acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.
Antimicrob. Agents Chemother.
40:1274-1276[Abstract].
|
| 7.
|
De Lucca, A. J.,
J. M. Bland,
T. J. Jacks,
C. Grimm,
T. E. Cleveland, and T. J. Walsh.
1997.
Fungicidal activity of cecropin A.
Antimicrob. Agents Chemother.
41:481-483[Abstract].
|
| 8.
|
De Lucca, A. J.,
T. J. Jacks,
J. M. Bland,
C. Grimm,
T. E. Cleveland, and T. J. Walsh.
1998.
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin.
Med. Mycol.
36:291-298.
[Medline] |
| 9.
|
Denning, D. W., and D. A. Stephens.
1990.
Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 cases.
Rev. Infect. Dis.
12:1147-1201[Medline].
|
| 10.
|
Feigin, A. M.,
J. Y. Takemoto,
R. Wangspa,
J. H. Teeter, and J. G. Brand.
1996.
Properties of voltage-gated ion channels formed by syringomycin-E in planar lipid bilayer.
J. Membr. Biol.
149:41-47[Medline].
|
| 11.
|
Hultmark, D.,
H. Steiner,
T. Rasmuson, and H. G. Boman.
1980.
Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia.
Eur. J. Biochem.
106:7-16[Medline].
|
| 12.
|
Hultmark, D.,
Å. Engström,
K. Andersson,
H. Bennisch,
R. Kapur, and H. G. Boman.
1982.
Insect immunity. Isolation and structure of cecropin D and four minor antibacterial components from cecropia pupae.
Eur. J. Biochem.
127:207-217[Medline].
|
| 13.
|
Lee, J.-Y.,
A. Bowman,
S. Chuaxin,
M. Anderson,
H. Mutt,
H. Jörnvall,
V. Mutt, and H. G. Boman.
1989.
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin.
Proc. Natl. Acad. Sci. USA
86:9159-9162[Abstract/Free Full Text].
|
| 14.
|
Medoff, G.
1988.
The mechanism of action of amphotericin, p. 161-164.
In
H. Vanden-Bossche, D. W. R. Mackenzie, and G. Cauwenbergh (ed.), Aspergillus and aspergillosis. Plenum Press, New York, N.Y.
|
| 15.
|
Pennington, J. E.
1993.
Aspergillus, p. 133-147.
In
G. A. Sarosi, and S. F. Davies (ed.), Fungal diseases of the lung, 2nd ed. Raven Press, New York, N.Y.
|
| 16.
|
Rabodonirina, M.,
M. A. Piens,
M. F. Monier,
E. Gueho,
D. Fiere, and M. Mojon.
1994.
Fusarium infections in immunocompromised patients: case reports and literature review.
Eur. J. Clin. Microbiol. Infect. Dis.
13:152-161[Medline].
|
| 17.
|
Segre, A.,
R. C. Bachman,
A. Ballio,
F. Bossa,
I. Grgurina,
N. S. Iacobellis,
G. Marino,
P. Pucci,
M. Simmaco, and J. Y. Takemoto.
1989.
The structure of syringomycins A1, E, and G.
FEBS Lett.
255:27-31[Medline].
|
| 18.
|
Sorensen, K. N.,
K.-H. Kim, and J. Y. Takemoto.
1996.
In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae.
Antimicrob. Agents Chemother.
40:2710-2713[Abstract].
|
| 19.
|
Sorensen, K. N.,
A. A. Wanstrom,
S. D. Allen, and J. Y. Takemoto.
1998.
Efficacy of syringomycin-E in a murine model of vaginal candidiasis.
J. Antibiot.
51:743-749[Medline].
|
| 20.
|
Taguchi, N.,
Y. Takano,
C. Julmanop,
Y. Wang,
S. Stock,
J. Takemoto, and T. Miyakawa.
1994.
Identification and analysis of the Saccharomyces cerevisiae SYR1 gene reveals that ergosterol is involved in the action of syringomycin.
Microbiology
140:353-359[Abstract].
|
| 21.
|
Takemoto, J. Y.
1992.
Bacterial phytotoxin syringomycin and its interaction with host membranes, p. 247-260.
In
D. P. S. Verma (ed.), Molecular signals in plant-microbe communication. CRC Press, Boca Raton, Fla.
|
| 22.
|
Waddell, W. R.
1956.
A simple ultraviolet spectrophotometric method for the determination of protein.
J. Clin. Med.
48:311-314.
|
| 23.
|
Walsh, T. J., and D. M. Dixon.
1989.
Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis, and treatment.
Eur. J. Epidemiol.
5:131-142[Medline].
|
| 24.
|
Wolf, P.
1983.
A critical reappraisal of Waddell's technique for ultraviolet spectrophotometric protein estimation.
Anal. Biochem.
129:145-155[Medline].
|
Antimicrobial Agents and Chemotherapy, February 1999, p. 371-373, Vol. 43, No. 2
0066-4804/99/$00.00+0